Published in J Immunol on September 28, 2016
Reslizumab and Eosinophilic Asthma: One Step Closer to Precision Medicine? Front Immunol (2017) 0.75
Understanding Interleukin 33 and Its Roles in Eosinophil Development. Front Med (Lausanne) (2017) 0.75
Eosinophils in Autoimmune Diseases. Front Immunol (2017) 0.75
Bidirectional Mast Cell-Eosinophil Interactions in Inflammatory Disorders and Cancer. Front Med (Lausanne) (2017) 0.75
IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity (2005) 14.95
Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature (2010) 10.34
The eosinophil. Annu Rev Immunol (2006) 7.06
The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel 'alarmin'? PLoS One (2008) 4.52
T1/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector function. Proc Natl Acad Sci U S A (1998) 3.61
IL-33 amplifies the polarization of alternatively activated macrophages that contribute to airway inflammation. J Immunol (2009) 3.41
Eosinophilia in transgenic mice expressing interleukin 5. J Exp Med (1990) 3.29
IL-5-deficient mice have a developmental defect in CD5+ B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses. Immunity (1996) 3.23
Type 2 innate lymphoid cells control eosinophil homeostasis. Nature (2013) 3.20
Eosinophils: changing perspectives in health and disease. Nat Rev Immunol (2012) 2.69
Expression of IL-5 in thymocytes/T cells leads to the development of a massive eosinophilia, extramedullary eosinophilopoiesis, and unique histopathologies. J Immunol (1997) 2.30
Functionally competent eosinophils differentiated ex vivo in high purity from normal mouse bone marrow. J Immunol (2008) 2.22
Identification of a lymphokine that stimulates eosinophil differentiation in vitro. Its relationship to interleukin 3, and functional properties of eosinophils produced in cultures. J Exp Med (1985) 2.22
An IL-1 cytokine member, IL-33, induces human basophil activation via its ST2 receptor. J Immunol (2008) 1.96
Identification of eosinophil lineage-committed progenitors in the murine bone marrow. J Exp Med (2005) 1.76
IL-33 exacerbates eosinophil-mediated airway inflammation. J Immunol (2010) 1.73
IL-33 induces neutrophil migration in rheumatoid arthritis and is a target of anti-TNF therapy. Ann Rheum Dis (2010) 1.62
IL-33, but not thymic stromal lymphopoietin or IL-25, is central to mite and peanut allergic sensitization. J Allergy Clin Immunol (2012) 1.59
CD34+ hemopoietic progenitor cells are potent effectors of allergic inflammation. J Allergy Clin Immunol (2008) 1.56
IL-33 is produced by mast cells and regulates IgE-dependent inflammation. PLoS One (2010) 1.54
Trefoil factor 2 rapidly induces interleukin 33 to promote type 2 immunity during allergic asthma and hookworm infection. J Exp Med (2012) 1.49
IL-33 and IL-33 receptors in host defense and diseases. Allergol Int (2010) 1.48
Molecular and clinical rationale for therapeutic targeting of interleukin-5 and its receptor. Clin Exp Allergy (2011) 1.30
Lineage(-)Sca1+c-Kit(-)CD25+ cells are IL-33-responsive type 2 innate cells in the mouse bone marrow. J Immunol (2011) 1.22
IL-33-dependent induction of allergic lung inflammation by FcγRIII signaling. J Clin Invest (2013) 1.08
Antigen profiles for the quantitative assessment of eosinophils in mouse tissues by flow cytometry. J Immunol Methods (2011) 1.02
Interleukin 5 is protective during sepsis in an eosinophil-independent manner. Am J Respir Crit Care Med (2012) 1.00
Gene microarray analysis reveals interleukin-5-dependent transcriptional targets in mouse bone marrow. Blood (2003) 0.97
Intraperitoneal influx of neutrophils in response to IL-33 is mast cell-dependent. Blood (2012) 0.96
Expression of IL-5 alters bone metabolism and induces ossification of the spleen in transgenic mice. J Clin Invest (2001) 0.96
IL-33-induced hematopoietic stem and progenitor cell mobilization depends upon CCR2. J Immunol (2014) 0.92
The role of IL-33 and mast cells in allergy and inflammation. Clin Transl Allergy (2015) 0.91
Interleukin-33: a mediator of inflammation targeting hematopoietic stem and progenitor cells and their progenies. Front Immunol (2013) 0.91
Thymic stromal lymphopoietin and IL-33 modulate migration of hematopoietic progenitor cells in patients with allergic asthma. J Allergy Clin Immunol (2015) 0.91
Enhanced histopathology of the bone marrow. Toxicol Pathol (2006) 0.90
Interleukin (IL)-33: new therapeutic target for atopic diseases. J Pharmacol Sci (2014) 0.90
IL-33 signaling contributes to the pathogenesis of myeloproliferative neoplasms. J Clin Invest (2015) 0.89
IL-25 and IL-33 Contribute to Development of Eosinophilic Airway Inflammation in Epicutaneously Antigen-Sensitized Mice. PLoS One (2015) 0.88
IL-33, but not IL-25, is crucial for the development of house dust mite antigen-induced allergic rhinitis. PLoS One (2013) 0.88
IL-33 promotes eosinophilia in vivo and antagonizes IL-5-dependent eosinophil hematopoiesis ex vivo. Immunol Lett (2012) 0.88
Transcription Factor Repertoire of Homeostatic Eosinophilopoiesis. J Immunol (2015) 0.84
TLR-induced activation of neutrophils promotes histamine production via a PI3 kinase dependent mechanism. Immunol Lett (2011) 0.83
Comparative analysis of the kinetics of binding and internalization of IL-5 in murine IL-5 receptors of high and low affinity. J Immunol (1993) 0.81
Severe neutrophil-dominated inflammation and enhanced myelopoiesis in IL-33-overexpressing CMV/IL33 mice. J Immunol (2014) 0.78
Transcriptional Heterogeneity of Mast Cells and Basophils upon Activation. J Immunol (2017) 0.75